Effect of eribulin in patients with metastatic breast cancer on circulating TGFβ and TNFα: The TRANSERI project

Trial Profile

Effect of eribulin in patients with metastatic breast cancer on circulating TGFβ and TNFα: The TRANSERI project

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Jan 2018

At a glance

  • Drugs Eribulin (Primary)
  • Indications Advanced breast cancer
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms The TRANSERI project; TRANSERI
  • Most Recent Events

    • 16 Jan 2018 New trial record
    • 09 Dec 2017 Results presented at the 40th Annual San Antonio Breast Cancer Symposium
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top